Summary & Overview
HCPCS G8899: Inflammatory Bowel Disease Measures Group Reporting
HCPCS Level II code G8899 signals a provider's intent to report the inflammatory bowel disease (IBD) measures group for quality and performance tracking. Nationally, standardized measure reporting supports care coordination, value-based contracting, and population health management for chronic IBD conditions by capturing adherence to guideline-based processes and outcomes. The code itself denotes reporting intent rather than a specific clinical service or procedure, and it plays a role in quality program workflows across payers.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, typical service settings, and which stakeholders commonly use the code. The publication outlines benchmarking use cases, implications for payer reporting requirements, and the clinical context of IBD measure sets. It also notes available benchmarks and policy update considerations where applicable.
This summary is designed for clinicians, billing staff, quality managers, and payers who need clarity on how HCPCS Level II code G8899 functions within quality reporting workflows and national payer programs.
Billing Code Overview
HCPCS Level II code G8899 indicates the provider's intention to report the inflammatory bowel disease (IBD) measures group. This code is used when a clinician or reporting entity plans to submit quality or performance measures specifically related to IBD care.
-
Service type: Quality measure reporting/registry submission
-
Typical site of service: Outpatient specialty clinics (gastroenterology), ambulatory care settings, and other locations where IBD care coordination and quality reporting occur.
Clinical & Coding Specifications
Clinical Context
A patient with known inflammatory bowel disease (Crohn disease or ulcerative colitis) presents for enrollment or reporting in a quality measurement program focused on IBD care. Typical patients are adults or adolescents with a documented IBD diagnosis who have had recent clinic visits, medication management, laboratory monitoring, or endoscopic evaluation. The clinical workflow begins when a gastroenterology clinic or health system identifies eligible patients for the IBD measures group, confirms active IBD diagnosis in the medical record, collects recent encounter and treatment data (medications, vaccinations, labs, endoscopy reports), and submits quality reporting data to a registry or payer. The encounter may occur in an outpatient gastroenterology clinic, hospital-based outpatient department, or ambulatory surgery center when measures require procedural documentation. Typical care team members include a gastroenterologist, registered nurse, medical assistant, and clinical quality coordinator. Documentation required for reporting includes signed provider notes stating diagnosis, medication lists (e.g., biologic therapy), laboratory results (CRP, fecal calprotectin), vaccination records, and procedure reports if relevant. The service represented by G8899 is administrative/reporting intent to indicate the provider plans to report the inflammatory bowel disease measures group for quality measurement purposes; it does not itself represent a billed clinical service such as an office visit or procedure but is tied to quality reporting workflows within outpatient gastroenterology and related ambulatory settings.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|